Sugar-Free Paracetamol Liquid Formulation for Stability and Palatability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing liquid pharmaceutical formulations of paracetamol often suffer from sedimentation and instability, leading to uneven concentration and unpleasant taste, especially in sugar-based solutions that are not suitable for low-sugar diets or patients with swallowing difficulties.

Innovation Solution

A sugar-free liquid pharmaceutical formulation containing an aqueous solution of paracetamol, polyethylene glycol as a solubilizing agent, xanthan gum as a thickening agent, and a sweetening system comprising sucralose and a mixture of polyols like glycerol, sorbitol, and xylitol, which maintains paracetamol in solution and provides a pleasant taste.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If paracetamol is suspended in liquid pharmaceutical form, then solubility issues are addressed, but sedimentation and instability occur over time

Engineering Contradiction:
ImprovestabilityVSAvoidsedimentation
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent changes the physical state of paracetamol from suspended solid particles to dissolved molecular form by optimizing the aqueous solution parameters. This is achieved through specific pH control (using citric acid and sodium citrate buffer system) and temperature management during preparation, allowing complete dissolution of paracetamol without suspension, thereby eliminating sedimentation while maintaining stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces buffer systems (citric acid and sodium citrate) as intermediary substances that mediate between paracetamol and water to achieve complete dissolution. These intermediaries control the pH environment to optimize paracetamol solubility and prevent precipitation, ensuring both stability and reliability of the formulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If sugar-based sweetening agents are used, then palatability is improved, but suitability for low-sugar diets is reduced

Engineering Contradiction:
ImprovepalatabilityVSAvoidsuitability for low-sugar diets
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent substitutes sugar-based sweetening agents with non-sugar alternatives (such as sucralose or other artificial sweeteners), changing the chemical composition parameters while maintaining the sweetening function. This allows the formulation to provide good palatability without containing sugars, making it suitable for both general use and low-sugar/ diabetic diets.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts and removes sugar components from the sweetening system while retaining the essential sweetening function through alternative substances. This extraction of the harmful element (sugar) while preserving the beneficial function (palatability) resolves the contradiction between taste quality and dietary suitability.

Inventive Principle:
Principle #2Taking out (Extraction)

3Quantity of substance

If paracetamol concentration is increased, then therapeutic efficacy is improved, but solubility and stability are compromised

Engineering Contradiction:
Improveparacetamol concentrationVSAvoidsolubility
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent optimizes multiple solution parameters simultaneously - pH (using buffer system), temperature (controlled during preparation), and ionic strength (through buffer composition) - to maximize paracetamol solubility. This allows achieving high therapeutic concentrations (up to 12.5% or 125 mg/ml) while maintaining complete solubility and stability without precipitation or degradation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The buffer system serves multiple functions: it controls pH to optimize solubility, acts as a stabilizer to prevent degradation, and maintains ionic strength for consistent solubility at high concentrations. This multi-functionality allows high paracetamol concentration while maintaining all required stability parameters.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Ease of operation

If liquid pharmaceutical form is used, then ease of administration is improved, but bitter taste becomes more problematic

Engineering Contradiction:
Improveease of administrationVSAvoidbitter taste
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the bitter taste characteristic from the formulation by using complete dissolution of paracetamol in optimized aqueous solution, which prevents the crystalline structure that causes bitterness. Additionally, non-sugar sweetening agents are used to counteract any remaining bitter notes, making the liquid form pleasant-tasting while maintaining ease of administration.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the molecular environment of paracetamol through pH optimization and complete dissolution, which alters the taste profile from bitter to more acceptable. The buffer system and sweetening agents work together to modify the taste parameters, making the liquid formulation palatable while retaining the advantages of liquid administration.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation maintains paracetamol stability over time, prevents darkening, and offers excellent palatability comparable to conventional syrups, making it suitable for patients with unpleasant taste issues and those on low-sugar diets.

Implementation Method 1

a solubilizing agent containing polyethylene glycol

Methodology Applied
Scientific EffectSolubilization: Solvation

Implementation Method 2

a thickening agent containing xanthan gum

Methodology Applied
Scientific EffectThickening: Viscoelasticity

Data Source

PatentEP2349207B1Liquid pharmaceutical formulation containing paracetamol
Publication Date: 2015.05.13 AZIENDE CHIMHE RIUNITE ANGELINI FRANCESCO A C R A F
  • EP2349207B1 patent drawing

AI summary

The present invention relates to a sugar-free liquid pharmaceutical formulation comprising an aqueous solution of paracetamol, a solubilizing agent containing polyethylene glycol, a thickening agent containing xanthan gum, and a sweetening system containing sucralose and a mixture of polyols containing glycerol, sorbitol and xylitol in a total amount between approx. 15% and 35% w/v relative to the total volume of said pharmaceutical formulation.